Antibody Design Labs


Founded in 2011, Antibody Design Labs is committed to become a leader in the field of recombinant antibody technologies. Over the last 30 years, techniques have rapidly evolved to make antibodies a primary component of modern research, modern diagnostic, and emerging therapeutics.  Following the initial discovery of monoclonal hybridomas, technologies such as phage display have become routine in many laboratories.  Still, getting the right antibody for the right application can be a long journey where high-throughput approaches can be very effective but at prohibitive costs.  Antibody Design Labs will be a centralized place to access tools, information, techniques in the field of recombinant antibody generation, engineering and design.

Antibody Design Labs is offering a wide choice of phage & phagemid vectors to overcome the challenge of phage display. Selection of binders is a complex process depending on multiple variables and experimental conditions, making time and resources the main limiting factors for successful biopannings. We currently offer varied options for display on the N-terminal side of the full-length gene III protein with the PelB leader peptide either using a phagemid system or phage vectors. The phagemids are best suited for the display of antibodies such as scFv and Fab fragments but can also be used to display peptides at a low valency; phage vectors produce a multivalent display and are best suited for peptides and scFv. This short guide will help you with the choice of the vector that best suits your project.
  • Multiple tags and cloning sites.
  • Varied display strategies.
  • No background expression to maintain library integrity & stability.
  • Inducible expression & display.